Darmstadt, Germany (ots/PRNewswire) - - Multiple sclerosis diagnosis has a profound impact on life choices including education, career, family planning and relationships - Almost 90% of women say multiple sclerosis played a role in their separation or divorce following diagnosis - Policy interventions could help address significant gender-specific challenges Merck, a ...
Nuremberg, Germany (ots/PRNewswire) - Factors rated "very" or "extremely" important by consumers Nearly half of consumers report that "low sugar or sugar-free" and "free from GMO ingredients" are very or extremely important factors when deciding which food or beverage product to eat or drink. These factors top the list, just ahead of factors such as low-salt, organic, ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for US/UK based media Merck to Present New Data on MS Portfolio: Rebif, Mavenclad, and Evobrutinib at ECTRIMS 2017 - Important safety and immune cell analyses further characterize the selective immune reconstitution approach of Mavenclad - Continued innovation with Rebif includes analysis of NEDA and use of MAGNIMS ...
Münster, Germany (ots/PRNewswire) - Comprehensive cooperation in terms of technology development, localized production and commercialization COMPO EXPERT GmbH (COMPO EXPERT), a leading manufacturer of specialty fertilizers for commercial use and portfolio company of the London-headquartered global private equity ...
Nuremberg, Germany (ots/PRNewswire) - One in three now include "take a break from technology" in their health routine. Nuremberg, September 28, 2017 - When it comes to which activities people do regularly to maintain their physical health, it is no surprise that nearly two thirds of the online population across 17 ...
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canadian and UK-based media - First-ever treatment indicated for curatively unresectable Merkel cell carcinoma (MCC) and first anti-PD-L1 to be available in Japan - Japanese Ministry of Health, Labour and Welfare (MHLW) decision based on Javelin Merkel 200 study, the largest registrational trial for an immunotherapy in MCC - First Asian approval for ...
Darmstadt, Germany, and New York, Usa (ots/PRNewswire) - Not intended for US, Canadian and UK-based media - First approved immunotherapy for rare and aggressive skin cancer in the European Union, with initial launches planned in Germany and the UK - Builds on Bavencio's previous accelerated approvals in the US and recent approval in Switzerland - Approval is based on ...
Karlsruhe, Germany (ots) - - Cross reference: Picture is available at http://www.presseportal.de/pm/119247/3740239 - Cinemo's Unified Media Solution presented on a next generation In-Vehicle Infotainment (IVI) prototype Cinemo, a global leader in high performance and automotive grade multimedia playback, streaming, media management, connectivity and cloud access middleware, and Bosch Car Multimedia, a supplier of intelligent solutions, that help make the integration of ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.K./U.S. based media - Big data platform to help accelerate innovative discovery, development and delivery of new approaches in cancer care - Enhanced analytical capabilities to better define personalized treatment options and help predict treatment outcomes - Focused on areas of high unmet need to help enhance ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK/U.S. based media - EUR1 million grant funded by Merck supports research with the potential to advance implementation of personalized treatment for solid tumors - Three winners selected from 100 scientifically diverse applicants worldwide Merck, a leading ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK-based media - Data to showcase Merck KGaA, Darmstadt, Germany's strong and diverse pipeline ranging from immuno-oncology to DNA damage response - Avelumab data validate potential in hard-to-treat cancers and highlight progress of the JAVELIN clinical ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.K. or U.S. based media ESMO 2017 abstract # Erbitux®: 576P, 593P, 1068P, 1579P; avelumab: 1227P, 913P, 1377TiP, 882P, 856P; M6620 (ATR inhibitor): 242PD; M2698 (dual p70S6K/Akt inhibitor): 370PD, 393P; tepotinib (c-Met kinase inhibitor): 701P - Data to showcase Merck's strong and diverse pipeline ranging from ...
Darmstadt, Germany (ots/PRNewswire) - - First oral short-course treatment for highly active relapsing multiple sclerosis (RMS)[1] now approved in Europe - MAVENCLAD® has shown sustained clinical efficacy for up to 4 years with a maximum of 20 days of oral treatment over 2 years - Marketing authorization includes the 28 countries of the European Union (EU), with first ...
Nuremberg, Germany (ots/PRNewswire) - - Garden centers should target people in their thirties and households with children under 12 years old, according to GfK Nearly a third of the online population across 17 countries does gardening or yard work either daily or weekly, according to data just published by GfK. This ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.K./U.S. based media - Decision secures access to Erbitux® for new patients in England with oral cavity tumors - All patients currently receiving Erbitux® will have continued access Merck, a leading science and technology company, announced today that the ...
Nuremberg, Germany (ots/PRNewswire) - On average, a quarter of people entertain guests in their home (http://www.gfk.com/global-studies/global-studies-frequency-of-entertaining-guests-at-home/) either daily or weekly, and a further third entertain monthly. Less than one in ten people say that they never entertain ...
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canadian and UK-based media - If approved, avelumab could be the first immunotherapy treatment indicated for this rare and aggressive skin cancer in the EU - Decision by the EC is expected in the third quarter of 2017 Merck and Pfizer Inc. (NYSE: PFE) today announced that the Committee for ...
Nuremberg, Germany (ots/PRNewswire) - - One in three people find it difficult to take a break from technology, even when they know they should - China, Brazil and Argentina have highest levels who struggle to take a tech break - People in Germany, The Netherlands and Belgium lead for finding it easy to 'unplug' A ...
Norderstedt, Germany (ots/PRNewswire) - The ECHELON FLEX(TM) GST System now features a 45mm endocutter intended for use in very thick tissue[5], making it suitable across a range of specialties Building on the success of the ECHELON FLEX(TM) 60mm Powered Plus Stapler with Gripping Surface Technology (GST), Ethicon*, a leading global provider of medical devices, today ...
Darmstadt, Germany (ots/PRNewswire) - - Data suggest that MAVENCLAD(TM) (Cladribine Tablets) selectively and discontinuously reduces B and T lymphocytes, with lymphocyte counts returning to normal range before the end of Year 2 - The lymphocyte data presented at EAN Congress are consistent with other clinical safety ...
Darmstadt, Germany (ots/PRNewswire) - - New data builds on company's longstanding commitment to MS Merck, a leading science and technology company, will present data from its neurology and immunology portfolio at the 3rd Congress of the European Academy of Neurology (EAN), taking place from June 24-27, in Amsterdam, ...
Darmstadt, Germany (ots/PRNewswire) - - Efficacy and safety data support positive benefit/risk assessment from CHMP - Cladribine Tablets is the first and only investigational medicinal product to have shown a sustained 4 years of disease control with a maximum of 20 days of oral treatment over 2 years in clinical ...
Johnson & Johnson Medical GmbH
Norderstedt, Germany (ots/PRNewswire) - Leveraging 130 years of knowledge and expertise across the Johnson & Johnson Family of Companies, Johnson & Johnson Medical Devices (JJMD) is proud to launch a new approach to help drive value-based healthcare in hospitals across Europe, Middle East and Africa (EMEA) - ...
Nuremberg, Germany (ots/PRNewswire) - One of the leading TV media currencies worldwide, MMS - which measures the moving image in Sweden - has released its digital ad ratings service. The service covers video advertisements on broadcasters' websites and apps viewed across PC, smartphone, tablet and smart TV. It is built upon GfK's data integration and data science capabilities that fuse MMS's multi-source data streams into ...
Darmstadt, Germany (ots/PRNewswire) - - Preliminary research indicates most MS carers are between the ages of 18-34, the prime of their lives - Largest global MS carer survey with International Alliance of Carer Organizations (IACO) to help identify unmet needs and social impact Merck, a leading science and technology company, honors World MS Day 2017 by announcing a ...
Nuremberg, Germany (ots/PRNewswire) - - Internationally, three times more people firmly agree than disagree in wanting more time over more money - Even among people with low income, twice as many firmly agree than disagree - For those aged 60+, the gap narrows significantly In an online survey just released by global research experts, GfK, three out of ten people (31 ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or U.S.-based media ASCO Abstract # M7824 (anti-PD-L1/TGF-ß trap): 3006; Avelumab: 9086, 9530, 9557, 4528, 3059, 5037, e21070, e21065, e20581; Tepotinib: 4087, 8547, e15676, 20541; M3814 (DNA-PK): 2556, e14048; M7583 (BTKi): e14101 - ASCO data highlights ...
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canada and UK-based media - A total of 13 abstracts across seven hard-to-treat cancers highlight the progress of avelumab as a monotherapy and potential novel combination treatment option - New data in metastatic Merkel cell carcinoma and ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S. and UK based media - With this approval, Pergoveris® becomes the first product with a combination of FSH and LH hormones in a ready-to-use liquid version - The new pre-filled injection device for self-administration increases ease-of-use for patients ...
Aachen, Germany (ots) - - Grünenthal's new Innovation Hub in Greater Boston, U.S., shall accelerate easier access to and close collaboration with leading scientists and institutions - Grünenthal brings fully integrated R&D capabilities in pain to this community - there is no other company with so much focus on ...